Growing Industry Presence Pace® Life Sciences operates as a nimble CDMO with recent acquisitions and strategic partnerships, positioning the company to expand its service offerings and geographic reach within the pharmaceutical manufacturing sector.

Specialized Formulation Capabilities With expertise in sterile aqueous formulations and fill-finish manufacturing, Pace® offers critical services that are essential for biotech and pharma companies developing injectables and biologics, creating opportunities to serve clients in the early to late development stages.

Targeted Market Segment Pace® serves small to mid-sized firms with revenues between $1M and $10M, indicative of a focused client base that may benefit from tailored, cost-effective manufacturing solutions, opening avenues for upselling or expanding service contracts.

Established Network Through a nationwide network of CDMO and CRO sites, Pace® can efficiently support clients during various development phases, fostering long-term partnerships and repeat business by providing comprehensive, end-to-end development and manufacturing support.

Emerging Growth Potential As the biopharmaceutical industry continues to grow and innovate, Pace®'s strategic positioning and recent acquisition activities present opportunities for sales teams to offer expanded services such as formulation development, clinical trial support, and GMP manufacturing to a rising client base.